EUVIMEDEUVIMED entdecken
Fallbericht

Antimicrobial therapy for nontuberculous mycobacterial pulmonary disease improved hearing loss and normalized myeloperoxidase-anti-neutrophil cytoplasmic antibody level: A case report

Yutaka Tomishima iD, Masei Suda iD, Hiromichi Tamaki

Modern Rheumatology Case Reports · 2023

DOI: 10.1093/mrcr/rxac047 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2023. Verfasst von Yutaka Tomishima und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Thoracic Center, St. Luke's International Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Hearing Loss, Anti-Infective Agents, Otitis Media. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several case reports have indicated that nontuberculous mycobacterial pulmonary disease is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides. However, the effect of the treatment for nontuberculous mycobacterial pulmonary disease on anti-neutrophil cytoplasmic antibody-associated vasculitides remains unclear. An asymptomatic 80-year-old woman presented with nodular bronchiectasis. After 1 year, she developed a productive cough. Mycobacterial culture of the respiratory specimen revealed Mycobacterium avium. She was diagnosed with nontuberculous mycobacterial pulmonary disease based on the criteria proposed by the American Thoracic Society. Concurrently, she had hearing loss, tinnitus, and weight loss. A blood test showed an elevated level of myeloperoxidase-anti-neutrophil cytoplasmic antibody (107 IU/mL, normal level: <3.5 IU/mL). Bilateral otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis was diagnosed based on the diagnostic criteria proposed by the Japan Otological Society. After starting antimicrobial agents for the nontuberculous mycobacterial pulmonary disease, her pulmonary symptoms and hearing loss improved, and the level of myeloperoxidase-anti-neutrophil cytoplasmic antibody normalized. No immunosuppressive treatment was administered. The present case suggests that nontuberculous mycobacterial pulmonary disease can cause otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitides, and antimicrobial treatment for the nontuberculous mycobacterial pulmonary disease may resolve otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium Infections, NontuberculousHearing LossAnti-Infective AgentsOtitis MediaAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisLung DiseasesFemaleHumansAged, 80 and overAntibodies, Antineutrophil CytoplasmicPeroxidase

Stichwörter der Autor:innen

Anti-neutrophil cytoplasmic antibodyhearing lossnontuberculous mycobacteria

Substanzen

Antibodies, Antineutrophil CytoplasmicPeroxidaseAnti-Infective Agents

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Thoracic Center, St. Luke's International Hospital, Tokyo, Japan.
  • Department of Rheumatology, Suwa Central Hospital, Nagano, Japan.
  • Department of Rheumatology, St. Luke's International Hospital, Tokyo, Japan.

ORCID-Profile: Yutaka Tomishima, Masei Suda

Zitieren

APA

Tomishima, Y., Suda, M., & Tamaki, H. (2023). Antimicrobial therapy for nontuberculous mycobacterial pulmonary disease improved hearing loss and normalized myeloperoxidase-anti-neutrophil cytoplasmic antibody level: A case report. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxac047

Vancouver

Tomishima Y, Suda M, Tamaki H. Antimicrobial therapy for nontuberculous mycobacterial pulmonary disease improved hearing loss and normalized myeloperoxidase-anti-neutrophil cytoplasmic antibody level: A case report. Modern Rheumatology Case Reports. 2023. doi:10.1093/mrcr/rxac047

BibTeX
@article{Tomishima2023,
  author = {Tomishima, Yutaka and Suda, Masei and Tamaki, Hiromichi},
  title = {Antimicrobial therapy for nontuberculous mycobacterial pulmonary disease improved hearing loss and normalized myeloperoxidase-anti-neutrophil cytoplasmic antibody level: A case report},
  journal = {Modern Rheumatology Case Reports},
  year = {2023},
  doi = {10.1093/mrcr/rxac047}
}
Kostenlos starten →